相关实验视频
Updated: Sep 15, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
857
慢性瘤对女性生殖荷尔蒙的影响
Mahua Bhaduri1, Ippokratis Sarris1, Pirro Hysi2
1King's Fertility, King's College Hospital, The Fetal Medicine Foundation, London, UK.
Kidney international reports
|July 18, 2025
概括
患有慢性病 (CKD) 的女性表现出生殖荷尔蒙的改变,包括较高的素激素 (LH) 和较低的抗穆勒尔激素 (AMH),影响生育能力. 需要进一步的研究,以便在CKD患者中进行明智的计划生育.
科学领域:
- 生殖内分泌学 生殖内分泌学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 不孕症研究 不孕症研究
背景情况:
- 在患有慢性病 (CKD) 的女性中,辅助生殖技术 (ART) 的使用正在增加.
- 连接CKD与女性生育能力下降的机制仍然不太清楚.
- 接受生育治疗的CKD患者的荷尔蒙特征需要进一步调查.
研究的目的:
- 研究CKD对女性生殖激素水平的影响.
- 为了比较患有CKD和健康对照女性之间的荷尔蒙特征和卵巢储备标记.
- 探索激素水平与功能 (eGFR) 之间的相关性.
主要方法:
- 一项观察性队列研究涉及100名患有CKD的女性和57名健康对照.
- 测量生殖激素,包括FSH,LH,益生菌素,AMH等.
- 通过抗穆勒尔激素 (AMH) 和毛囊数 (AFC) 评估卵巢储备.
主要成果:
- 与对照组相比,患有CKD的女性的LH水平较高,AMH和AFC水平较低.
- 液水平与估计的淋巴细胞过率 (eGFR) 的下降有积极的相关性.
- 随着eGFR的下降,AMH和AFC的降低,以及益生菌水平的增加.
结论:
- 慢性瘤与关键生殖荷尔蒙和卵巢储备标志物的显著变化有关.
- 这些荷尔蒙变化可能导致CKD妇女的生育能力下降.
- 纵向研究对于指导患有CKD的女性生育决策至关重要.
相关概念视频
01:25Chronic Kidney Disease I: Introduction
74
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
74
01:24Chronic Kidney Disease II: Clinical Manifestations
101
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
101
01:28Chronic Kidney Disease III: Interprofessional Care
80
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
80
01:18Chronic Kidney Disease IV: Nursing Management
59
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
59
01:17Factors Affecting Renal Clearance: Renal Impairment
162
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
162
01:11Renal Failure: Dose Adjustments
161
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
161